Szabina Kádár

The Effect of the Particle Size Reduction on the Biorelevant Solubility and Dissolution of Poorly Soluble Drugs with Different Acid-Base Character

Dóra Csicsák, Rita Szolláth, Szabina Kádár et al. · Pharmaceutics · 2023 · 48 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Prediction of Bioequivalence and Food Effect Using Flux- and Solubility-Based Methods

Enikő Borbás, Szabina Kádár, Konstantin Tsinman et al. · Molecular Pharmaceutics · 2019 · 42 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Inclusion complexation of the anticancer drug pomalidomide with cyclodextrins: fast dissolution and improved solubility

Zoltán‐István Szabó, G Orban, Enikő Borbás et al. · Heliyon · 2021 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Cyclodextrin encapsulation enabling the anticancer repositioning of disulfiram: Preparation, analytical and in vitro biological characterization of the inclusion complexes

Beáta-Mária Benkő, Gergő Tóth, Dorottya Moldvai et al. · International Journal of Pharmaceutics · 2024 · 15 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Flux-Based Formulation Development—A Proof of Concept Study

Szabina Kádár, Petra Tőzsér, Brigitta Nagy et al. · The AAPS Journal · 2022 · 13 citations · Full text

Pharmacy, Pharmaceutics, Dissolution Testing +16